These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22474197)

  • 1. Recommendations on use of prostate-specific antigen for prostate cancer screening.
    Garnick MB
    JAMA; 2012 Apr; 307(13):1372; author reply 1372-4. PubMed ID: 22474197
    [No Abstract]   [Full Text] [Related]  

  • 2. Grading the new US Preventive Services Task Force prostate cancer screening recommendation.
    Volk RJ; Wolf AM
    JAMA; 2011 Dec; 306(24):2715-6. PubMed ID: 22203540
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer screening--time to abandon one-size-fits-all approach?
    Kim J; Davis JW
    JAMA; 2011 Dec; 306(24):2717-8. PubMed ID: 22203541
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostate cancer screening--the evidence, the recommendations, and the clinical implications.
    Chou R; LeFevre ML
    JAMA; 2011 Dec; 306(24):2721-2. PubMed ID: 22203543
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate specific antigen and screening for early prostate cancer.
    Davidson P
    N Z Med J; 2001 Apr; 114(1129):150. PubMed ID: 11400919
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for prostate cancer remains controversial.
    Neal DE; Donovan JL; Martin RM; Hamdy FC
    Lancet; 2009 Oct; 374(9700):1482-3. PubMed ID: 19664817
    [No Abstract]   [Full Text] [Related]  

  • 7. The United States Preventive Services Task Force recommendation against prostate-specific antigen screening--point.
    Ablin RJ
    Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):391-4. PubMed ID: 22315362
    [No Abstract]   [Full Text] [Related]  

  • 8. Making an informed choice about PSA screening.
    Ward J; Gattellari M
    Aust Fam Physician; 2001 Jul; 30(7):715-6. PubMed ID: 11558209
    [No Abstract]   [Full Text] [Related]  

  • 9. Missing the mark on prostate-specific antigen screening.
    Miller DC; Hollenbeck BK
    JAMA; 2011 Dec; 306(24):2719-20. PubMed ID: 22203542
    [No Abstract]   [Full Text] [Related]  

  • 10. Informed consent for prostate-specific antigen screening.
    Wilkinson S; Chodak G
    Urology; 2003 Jan; 61(1):2-4. PubMed ID: 12559252
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate cancer screening.
    Med Lett Drugs Ther; 2008 Nov; 50(1298):85-6. PubMed ID: 18978703
    [No Abstract]   [Full Text] [Related]  

  • 12. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
    Schröder FH
    N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
    [No Abstract]   [Full Text] [Related]  

  • 13. Informed consent for prostate-specific antigen screening.
    Catalona WJ
    Urology; 2003 Jan; 61(1):17-9. PubMed ID: 12559258
    [No Abstract]   [Full Text] [Related]  

  • 14. The jury is still out with regard to screening for the prostate cancer with prostate-specific antigen.
    Eur J Cancer Care (Engl); 2002 Jun; 11(2):78. PubMed ID: 12168606
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
    Brett AS; Ablin RJ
    N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
    [No Abstract]   [Full Text] [Related]  

  • 16. Informed consent for prostate-specific antigen-based screening.
    Brawley OW
    Urology; 2003 Jan; 61(1):10-2. PubMed ID: 12559255
    [No Abstract]   [Full Text] [Related]  

  • 17. Informed consent for prostate-specific antigen screening.
    Carter HB
    Urology; 2003 Jan; 61(1):13-4. PubMed ID: 12559256
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving appropriateness of prostate-specific antigen screening.
    Lippi G; Montagnana M; Guidi GC
    Arch Intern Med; 2007 Dec; 167(22):2529-30. PubMed ID: 18071182
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 20. [Opportunity for a systematic screening of prostatic cancer by determining prostate specific antigen levels].
    Cuzin B; Maisonneuve H; Thoral F; Charvet-Protat S
    Prog Urol; 2000 Feb; 10(1):124-7. PubMed ID: 10785932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.